跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 715 条关于
“integrin α4β7”
全部
715
临床试验
388
药物
76
机构
13
资讯
238
去年
Novel Oral α4β7 Integrin Inhibitor NSHO-101 Shows Promise for IBD Treatment in Phase 1 Data
2年前
PatientSeek Identifies Genetic Signature for Vedolizumab Response in Ulcerative Colitis
12个月前
C4X Discovery Selects Once-Daily Oral α4β7 Inhibitor Candidate for Inflammatory Bowel Disease Treatment
去年
Spyre Therapeutics Advances IBD Pipeline with SPY001 and SPY002 Programs
2个月前
Attovia Therapeutics Raises $289M in Upsized IPO to Advance Biparatopic Nanobody Pipeline in Immunology
8年前
Vedolizumab: A New Therapeutic Option for Inflammatory Bowel Disease
去年
Biopharma M&A Activity Reaches $79.4 Billion in 2024 Despite 50% Drop from Previous Year
7个月前
Omvoh Demonstrates Three-Year Steroid-Free Remission in Crohn's Disease Patients
去年
Alphamab Oncology Receives IND Approval for First-in-Class Bispecific ADC JSKN022 Targeting PD-L1 and Integrin αvβ6
去年
Sigvotatug Vedotin Shows Promise in NSCLC as Novel Integrin Beta-6 Targeted ADC Advances to Phase 3
第 1 页,共 24 页
上一页
下一页